Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle R Lofwall

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|September 1, 2016
Putting Parity into Practice - Integrating Opioid-Use Disorder Treatment into the Hospital SettingLaura Fanucchi, Michelle R Lofwall
Journal of Addiction Medicine|July 20, 2011
Clinical challenges in managing buprenorphine diversionMichelle R Lofwall, Sharon L Walsh
Journal of Addiction Medicine|September 16, 2014
A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the worldMichelle R Lofwall, Sharon L Walsh
Preventive Medicine|August 5, 2021
Long-acting buprenorphine injectables: Opportunity to improve opioid use disorder treatment among rural populationsMichelle R Lofwall, Laura C Fanucchi
Drug and Alcohol Dependence|June 19, 2012
Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphineMichelle R Lofwall, Jennifer R Havens
Journal of Psychiatric Practice|March 19, 2015
Challenges of the capacity evaluation for the consultation-liaison psychiatristMegan M White, Michelle R Lofwall
The International Journal on Drug Policy|August 3, 2025
Interpreting extended-release buprenorphine data: The importance of specifying formulations and accurately representing prior evidenceMichelle R Lofwall, Natalie R Budilovsky-Kelley
The Journal of Nervous and Mental Disease|December 17, 2008
Changing profile of abused substances by older persons entering treatmentMichelle R Lofwall, Alyson Schuster, Eric C Strain
The American Journal of Psychiatry|May 2, 2015
Abuse and diversion of gabapentin among nonmedical prescription opioid users in Appalachian KentuckyRachel V Smith, Michelle R Lofwall, Jennifer R Havens
Journal of Addiction Medicine|December 12, 2018
Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting FormulationsMarion A Coe, Michelle R Lofwall, Sharon L Walsh
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|September 1, 2016
Putting Parity into Practice - Integrating Opioid-Use Disorder Treatment into the Hospital SettingLaura Fanucchi, Michelle R Lofwall
Journal of Addiction Medicine|July 20, 2011
Clinical challenges in managing buprenorphine diversionMichelle R Lofwall, Sharon L Walsh
Journal of Addiction Medicine|September 16, 2014
A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the worldMichelle R Lofwall, Sharon L Walsh
Preventive Medicine|August 5, 2021
Long-acting buprenorphine injectables: Opportunity to improve opioid use disorder treatment among rural populationsMichelle R Lofwall, Laura C Fanucchi
Drug and Alcohol Dependence|June 19, 2012
Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphineMichelle R Lofwall, Jennifer R Havens
Journal of Psychiatric Practice|March 19, 2015
Challenges of the capacity evaluation for the consultation-liaison psychiatristMegan M White, Michelle R Lofwall
The International Journal on Drug Policy|August 3, 2025
Interpreting extended-release buprenorphine data: The importance of specifying formulations and accurately representing prior evidenceMichelle R Lofwall, Natalie R Budilovsky-Kelley
The Journal of Nervous and Mental Disease|December 17, 2008
Changing profile of abused substances by older persons entering treatmentMichelle R Lofwall, Alyson Schuster, Eric C Strain
The American Journal of Psychiatry|May 2, 2015
Abuse and diversion of gabapentin among nonmedical prescription opioid users in Appalachian KentuckyRachel V Smith, Michelle R Lofwall, Jennifer R Havens
Journal of Addiction Medicine|December 12, 2018
Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting FormulationsMarion A Coe, Michelle R Lofwall, Sharon L Walsh
Pageof 13